The IDIGH Program Management Committee consists of representatives from all three pillars of the program (fundamental research, epidemiology & health outcome and clinical research), external (non-IDIGH program) members and trainees. Our committee meets 3-4 times/year to address issues related to the program and to discuss strategies and action points to move  the IDIGH program forward towards its objective of becoming a world leading centre for translational research in infectious and immune-mediated diseases of global importance.

 

 IDIGH Program Management Meeting. Photo by Jing Liu
IDIGH Program Management Meeting. Photo by Jing Liu

Management

Dr. Erwin Schurr (Program Leader)
Dr. Marcel Behr (Associate Program Leader)

Representatives of fundamental research

Dr. Nicole Bernard
Dr. Ciriaco Piccirillo

Representatives of epidemiology & health outcome research

Dr. Theresa Gyorkos
Dr. Marina Klein
Dr. Madhukar Pai

Representatives of clinical research

Dr. Don Sheppard
Dr. Marcel Behr

Representatives of graduate students and post-doctoral fellows

Lauren Nagel (co-president of the IDIGH trainee committee)
Tho-Alfakar Al-Aubodah (co-president of the IDIGH trainee committee)

External (non-IDIGH program) members

Dr. Maziar Divangahi
TBD

IDIGH Calendar

<<  <  July 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    1  2  3  4  5
  6  7  8  9101112
13141516171819
20212223242526
2728293031  

Latest IDIGH Publications

  1. Harris, M., Brouillette, M.-J., Scott, S. C., Smaill, F., Smith, G., Thomas, R., Fellows, L. K. & Mayo, N. E.
    (2020)
    .
    Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in Canada
    .
    Journal of acquired immune deficiency syndromes (1999)
    ,
    vol
    .
    84
    ,
    p
    .
    336-344
    .
  2. Balram, B., Lubov, J., Theoret, Y., Afif, W., Bitton, A., Wild, G., Lakatos, P. L. & Bessissow, T.
    (2020)
    .
    Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy
    .
    Digestive diseases and sciences
  3. Lima, N. S., Takata, H., Huang, S.-H., Haregot, A., Mitchell, J., Blackmore, S., Garland, A., Sy, A., Cartwright, P., Routy, J.-P., Michael, N. L., Appay, V., Jones, R. B. & Trautmann, L.
    (2020)
    .
    CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir
    .
    Journal of immunology (Baltimore, Md. : 1950)
  4. Langedijk, A. C., Lebbink, R. J., Naaktgeboren, C., Evers, A., Viveen, M. C., Greenough, A., Heikkinen, T., Stein, R. T., Richmond, P., Martinón-Torres, F., Nunes, M., Hosoya, M., Keller, C., Bauck, M., Cohen, R., Papenburg, J., Pernica, J., Hennus, M. P., Jin, H., Tabor, D. E., Tovchigrechko, A., Ruzin, A., Abram, M. E., Wilkins, D., Wildenbeest, J. G., Kragten-Tabatabaie, L., Coenjaerts, F. E. J., Esser, M. T. & Bont, L. J.
    (2020)
    .
    Global molecular diversity of RSV - the "INFORM RSV" study
    .
    BMC infectious diseases
    ,
    vol
    .
    20
    ,
    p
    .
    450
    .
  5. Mendel, A., Bernatsky, S., Askanase, A., Bae, S.-C., Clarke, A. E., Costedoat-Chalumeau, N., Gladman, D. D., Gordon, C., Hanly, J., Jacobsen, S., Kalunian, K., Mak, A., Mosca, M., Pons-Estel, B. A., Ruiz-Irastorza, G., Urowitz, M. & Vinet, É.
    (2020)
    .
    Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics
    .
    Annals of the rheumatic diseases
More publications